You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Bosnia-Herzegovina

Aug 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Bosnia-Herzegovina with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Bosnia-Herzegovina, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Bosnia-Herzegovina for free:

The Consumer Health in Bosnia-Herzegovina market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Bosnia-Herzegovina?
  • What are the major brands in Bosnia-Herzegovina?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Widening supply drives growth

Consumer health in Bosnia-Herzegovina developed strongly over the review period, driven mainly by expanded distribution across the country as chemists/pharmacies offered a widening range. Growth was also supported by ongoing growth in consumers’ disposable income levels. The range of products on offer significantly expanded during the review period, with both manufacturers and chemists/pharmacies offering a widening range due to tightening control on the UTC sale of Rx products.

Significant slow-down in response to economic downturn

2010 however saw the lowest annual current value growth for consumer health during the review period. This slowdown was due to a contraction in consumers’ disposable income levels as a result of the economic downturn. Despite this, consumer health outperformed many other areas in fast-moving consumer goods in 2010. Consumers are increasingly health-conscious and are also increasingly willing to self-medicate in response to the first symptoms of illness, particularly given a growing media and public focus on epidemics towards the end of the review period, such as N1H1. In addition, pharmacists became increasingly restrictive towards UTC sales of Rx products towards the end of the review period, with many consumers thus switching to OTC consumer health.

Regional and domestic players remain dominant

Regional and domestic pharmaceutical giants lead sales, with manufacturers such as Bosnalijek, Lek, Pliva, Krka, Hemofarm and Alkaloid benefiting from their long-term presence and strong consumer loyalty. However, during the review period there was increasing liberalisation for imports of consumer health. Consequently, many multinationals entered during the review period, such as Bayer in OTC and NBTY in vitamins and dietary supplements. Multinationals steadily improved their shares during the review period as a whole thanks to strong advertising support and widening distribution.

Distribution continues to widen

The distribution of consumer health continued to be dominated by chemists/pharmacies at the end of the review period. During the review period, new channels however began to emerge within areas such as vitamins and dietary supplements and weight management. Direct selling and homeshopping proved particularly successful in many areas, offering consumers access to a wider range of products. In addition, supermarkets began to offer a widening range of wound care and vitamins and dietary supplements during the review period. Many manufacturers pushed for wider distribution during the review period as they sought to improve availability for their products and to offer greater convenience for consumers.

Wealthier and better educated consumer base to drive growth

Consumer health is expected to see recovery from the negative effects of the economic downturn from 2011 onwards and is expected to see slightly stronger constant value growth during the forecast period than that seen during the review period. While review period growth was driven by widening distribution and an expanded product range, forecast period growth is expected to be demand-driven. Consumers will not merely be wealthier but will also become increasingly health-conscious. There will be a growing understanding of the product range on offer and stronger confidence in self-medication. Over the forecast period, pharmaceutical manufacturers are also expected to seek to switch more products to OTC status due to stricter regulations for Rx medicines in the form of price controls, advertising bans and tighter controls on UTC sales.

Table of Contents

Table of Contents

Consumer Health in Bosnia-Herzegovina - Industry Overview

EXECUTIVE SUMMARY

Widening supply drives growth

Significant slow-down in response to economic downturn

Regional and domestic players remain dominant

Distribution continues to widen

Wealthier and better educated consumer base to drive growth

KEY TRENDS AND DEVELOPMENTS

Increasingly restrictive stance taken towards UTC sales of Rx medicines

Changes seen in distribution landscape

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and dietary supplements registration and classification

Self-medication and preventative medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Bosnia-Herzegovina - Company Profiles

Belupo dd in Consumer Health (Bosnia-Herzegovina)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Belupo dd: Competitive Position 2010

Bosnalijek Pharmaceuticals dd in Consumer Health (Bosnia-Herzegovina)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Bosnalijek Pharmaceuticals dd: Competitive Position 2010

JU Apoteke Sarajevo in Consumer Health (Bosnia-Herzegovina)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 JU Apoteke Sarajevo: Competitive Position 2010

Adult Mouth Care in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care benefited from many chemists/pharmacies offering a widening product range towards the end of the review period. Leading players Bosnalijek Pharmaceuticals and CSC proved particularly active in pushing for a wider presence. This offered consumers a widening choice of products and supported ongoing current value sales growth in 2010, despite the impact of the economic downturn.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bosnalijek Pharmaceuticals and CSC Pharmaceuticals were the leading players in adult mouth care in 2010 with value shares of 52% and 22% respectively. These players benefit from having the widest distribution within adult mouth care and also from their well-differentiated products. Bosnalijek Pharmaceuticals offers Lysobact tablets, which contain vitamin B6 and anti-inflammatory agents to tackle the cause and symptoms of gingivitis and similar ailments. CSC meanwhile offers Tantum Verde mouthwash offering local anaesthetic and analgesic properties.

PROSPECTS

  • Adult mouth care is expected to benefit from growing consumer awareness and rising disposable income levels during the forecast period. Consumers will increasingly be attracted to these products when suffering from minor mouth complaints, with OTC purchases enabling them to avoid time-consuming doctors’ visits. As more choose to self-medicate in this area, adult mouth care will also benefit from word-of-mouth recommendations from family and friends, further boosting consumers’ confidence in self-medication.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • Consumers were used to being able to purchase most Rx analgesics without a prescription for much of the review period. However, tighter controls on UTC sales of analgesics began to be seen towards the end of the review period, following the elevation of drug control legislation to a state level in 2008. Greater sales restrictions on UTC products meanwhile boosted sales of OTC analgesics, with this trend softening the impact of the economic downturn at the end of the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer, Pliva and Alkaloid lead sales in analgesics, accounting for respective value shares of 21%, 16% and 15% in 2010. These players benefit from strong advertising support and wide distribution. Consequently, their products such as Alkaloid’s Caffetin, Pliva’s Andol and Bayer’s eponymous range enjoy strong consumer awareness and offer good availability. All three players also offer a wide range of products in analgesics.

PROSPECTS

  • The distinction between OTC and Rx status in analgesics is expected to become clearer during the forecast period among both pharmacists and consumers. As this occurs, there is expected to be a continued migration of sales from Rx to OTC during the forecast period, with consumers struggling to buy the Rx analgesics that they once relied upon. With rising public spending concerns, the country is also expected to see the introduction of more restrictive policies towards the subsidising of Rx drugs, with doctors becoming more reluctant to prescribe Rx analgesics for minor problems. These trends will inevitably support good OTC sales growth for analgesics and are likely to benefit the leading brands, as ex-Rx consumers opt for brands with a high profile and trusted image.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • There was growing concern over the misuse of prescription calming and sleeping products during the review period, with drug abuse being increasingly recognised as a serious problem in Bosnia-Herzegovina. Consequently, pharmacists were instructed to take a stricter stance towards UTC sales of calming and sleeping products during the review period. This resulted in many consumers switching from Rx to OTC calming and sleeping products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Lek continued to dominate sales of calming and sleeping products in 2010, with its Persen brand accounting for 51% value share. This brand benefits from its high quality image and a reputation for efficacy. It is frequently recommended by pharmacists and has a wide distribution presence in the country’s chemists/pharmacies.

PROSPECTS

  • Consumers are likely to continue to switch from Rx to OTC calming and sleeping products during the forecast period. Consumers will find it increasingly difficult to obtain Rx products without a license while there will also be growing awareness of the leading OTC brands due to advertising. Media coverage of the potential negative side-effects of Rx calming and sleeping products will also encourage this shift.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • There were a number of well-publicised flu epidemics towards the end of the review period, including epidemics of Mexican flu during autumn 2009 and winter 2009/2010. This increased consumers’ awareness of flu symptoms, with many turning to medication at the first signs of a cold in the hope of avoiding more serious infections. This trend bolstered sales during the difficult economic period seen at the end of the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Krka, Engelhard, Bosnalijek and Lek together lead sales in cough, cold and allergy (hay fever) remedies, with each controlling around 12% of total value sales in 2011. These players compete closely and benefit from their products’ strong distribution, widespread consumer brand recognition and a reputation for effectiveness.

PROSPECTS

  • In 2009 and 2010, OTC cough, cold and allergy (hay fever) remedies were increasingly regarded as effective prevention against more serious infections, even against the N1H1 virus. This consumer perception is expected to encourage ongoing self-medication for cold and flu symptoms during the forecast period, with consumers thus aiming to prevent more serious infections.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • Sales of digestive remedies were supported in 2010 by the outbreak of a major stomach virus during the summer months. The consumption of digestive remedies usually spikes during the summer months when stomach bugs are most common. The 2010 outbreak especially boosted sales of diarrhoeal remedies, with many consumers reaching for these products in order to relieve distressing symptoms. Consequently, diarrhoeal remedies saw an impressive 10% current value growth in 2010 over the previous year and was the most dynamic product area within digestive remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bosnalijek, Lek and Boehringer lead sales in digestive remedies, accounting for 21%, 17% and 15% value share respectively in 2010. These players benefit from their wide distribution networks and a strong reputation for efficacy. They also benefit from offering strong brands such as Bosnalijek’s Ranibos, Lek’s Linex and Boehringer’s Dulcolax.

PROSPECTS

  • Sales of digestive remedies may well be hit by healthier eating habits during the forecast period. Consumers are becoming increasingly aware of the links between digestive disorders and the quality of the food they eat. Consequently, many players are likely to seek healthier diets during the forecast period, eating more fruit and vegetables and paying more attention to food hygiene when buying and preparing ingredients. This trend could well reduce the incidence of digestive problems in Bosnia-Herzegovina during the forecast period.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • Ear care suffered in 2010 from a shift back from OTC to Rx products. During the review period, busier consumer lifestyles and rising income levels encouraged a growing number of consumers to self-medicate, as visits to doctors’ surgeries are generally very time-consuming. However, increasing economic uncertainty towards the end of the review period reversed this trend, with many consequently visiting doctors in order to obtain products on prescription and thus save money. Consequently, ear care saw 1% current value sales decline in 2010 over the previous year, with this in contrast to a review period current value CAGR of 3%.

SWITCHES

COMPETITIVE LANDSCAPE

  • The only brand present in ear care is Hemofarm’s Otol H. This has a widespread presence in chemists/pharmacies but suffers from a lack of marketing support, with this largely due to the lack of competition faced by the brand. There is consequently a lack of consumer awareness for Otol H.

PROSPECTS

  • Ear care is expected to remain a small niche during the forecast period. This product area is not expected to attract new entrants, due to poor sales at the end of the review period. However, this will in turn create a vicious circle, with an absence of marketing support and innovation in OTC ear care resulting in an ongoing lack of consumer interest. By the end of the forecast period, sales are expected to continue to total BAM0.1 million on an annual basis.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • Eye care suffered from a shift back to Rx medicines in 2010, with this particularly impacting allergy eye care. Allergy eye care is typically used on a long-term basis, with many consumers thus able to save considerable sums by seeking prescriptions rather than buying OTC. Consequently, consumers became more prepared to face time-consuming doctors’ visits, with allergy eye care seeing 2% current value decline in 2010 over the previous year as a result.

SWITCHES

COMPETITIVE LANDSCAPE

  • Only two manufacturers have a significant presence in eye care in Bosnia-Herzegovina: Hemofarm and Alkaloid. Hemofarm dominates with 61% value share thanks to offering both standard and allergy eye care in the form of the Hemodrops and Hemokulin brands respectively. The company is however strongest in standard eye care, with Hemodrops alone accounting for 59% value share in 2010.

PROSPECTS

  • Eye care remained underdeveloped at the end of the review period, with only two significant players. Over the forecast period, there may however be new launches if Rx controls are relaxed and switches permitted. One of most important factors constraining growth for eye care during the review period was the government’s restrictive stance towards awarding OTC status to eye care. Brands such as Johnson & Johnson’s Visine for example drove sales of eye care in many European countries but continued to be classified as Rx in Bosnia-Herzegovina at the end of the review period.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2005-2010
  • Table 48 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 49 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 50 Eye Care Company Shares 2006-2010
  • Table 51 Eye Care Brand Shares 2007-2010
  • Table 52 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • Within cough, cold and allergy (hay fever) remedies, herbal/traditional products saw a strong performance in 2010. Many consumers turned to cough, cold and allergy (hay fever) remedies due to concerns over a number of flu epidemics in the year and these consumers consequently began to use these products on a frequent or long-term basis in response to minor symptoms. As a result, many switched to herbal/traditional variants due to these products’ lower prices and safer and more natural image. Overall, herbal/traditional cough, cold and allergy (hay fever) remedies saw a strong 6% current value growth in 2010 over the previous year, rising to account for 42% value share in overall herbal/traditional products and a similar share in cough, cold and allergy (hay fever) remedies.

COMPETITIVE LANDSCAPE

  • Krka is a clear leader in herbal/traditional products, accounting for a steady 16% value share in 2010. This player offers a wide range of both brands and products, with its share derived from many product areas. The company is the leading player in herbal/traditional dietary supplements, where it accounted for 15% value share in 2010, and ranked second in herbal/traditional cough, cold and allergy (hay fever) remedies and medicated skin care with shares of 26% and 13% respectively. The company also has a significant value share in herbal/traditional calming and sleeping products and digestive remedies. The company benefits from a strong reputation for quality, with this based on word-of-mouth and pharmacists’ recommendations.

PROSPECTS

  • Herbal/traditional products is set to outperform standard consumer health in constant value terms over the forecast period. Consumers in Bosnia-Herzegovina are increasingly interested in the effects that medicines can have on their long-term health, with many thus set to switch to herbal/traditional products. The ageing population is also expected to benefit herbal/traditional products, with many older consumers seeking safe remedies that they can use on a long-term basis.

CATEGORY DATA

  • Table 54 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 55 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 56 Herbal/Traditional Products Company Shares 2006-2010
  • Table 57 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 58 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 59 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • Growth in medicated skin care continued to be supported by widening distribution for many product areas towards the end of the review period. The review period for example saw the introduction of cold sore treatments, which were offered by a widening range of chemists/pharmacies towards the end of the review period. This product area consequently saw the strongest current value growth in 2010 over the previous year at 14%. Acne treatments and hair loss treatments also gained share thanks to improved availability, with this particularly benefiting acne treatment kits, such as Murad, Afrodita and ProActive. While, many consumers find these products to be too expensive, they thus saw growing interest among high-income consumers.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bosnalijek, Bayer and Hemofarm lead sales of medicated skin care and accounted for respective value shares of 16%, 15% and 13% in 2010. These manufacturers invested most in expanding distribution for their products during the review period and in establishing them as recognisable brands through advertising. Brand awareness and reputation is often a major factor behind consumers’ purchasing decisions in this product area, with these players benefiting as a result.

PROSPECTS

  • Medicated skin care is likely to continue expanding sales strongly over the forecast period. Growth during the review period was mainly driven by a widening product range and expanded distribution. Growth during the forecast period is meanwhile set to be driven by demand factors. Consumers are likely to become increasingly willing to self-medicate and are also likely to become better educated about the range of products available. Higher disposable income levels will also enable consumers to buy medicated skin care more frequently.

CATEGORY DATA

  • Table 60 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 61 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 62 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 63 Medicated Skin Care Brand Shares 2007-2010
  • Table 64 Hair Loss Treatments Brand Shares 2007-2010
  • Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • There was growing health-awareness in Bosnia-Herzegovina during the review period, with many consumers trying to stop smoking as a result. However, NRT smoking cessation aids is too expensive for the majority of consumers, with sales consequently limited to mid- and high-income groups. The economic downturn seen towards the end of the review period further alienated consumers from NRT smoking cessation aids, with current value sales seeing 5% decline as a result. Consumers increasingly sought to stop smoking through using willpower instead in order to save money.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson is the only company present in NRT smoking cessation aids in Bosnia-Herzegovina, with the company having launched its Nicorette brand in the country in 2006. This brand is offered in two varieties: NRT gum and NRT patches. The company accounted for 100% of sales towards the end of the review period and benefited from wide distribution via chemists/pharmacies.

PROSPECTS

  • NRT smoking cessation aids is expected to see strong growth during the forecast period, with a constant value CAGR of 6%. Growth is likely to be underpinned by two main factors: growing health-consciousness and increasing consumer affluence. Consumers are expected to become more aware of the dangers of smoking during the forecast period and thus a growing number will seek to quit smoking. However, with many having failed to quit using willpower in the past, rising disposable income levels will result in an increasing uptake for NRT smoking cessation aids.

CATEGORY INDICATORS

  • Table 67 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 68 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2010
  • Table 69 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2010
  • Table 70 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 71 NRT Smoking Cessation Aids Company Shares 2006-2010
  • Table 72 NRT Smoking Cessation Aids Brand Shares 2007-2010
  • Table 73 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 74 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • The economic downturn had a marked impact on sales of sports nutrition in 2010. As consumers’ disposable income levels dropped, many moved away from sports nutrition due to its high price or switched to cheaper products. Many consumers notably opted for home-made alternatives, such as protein drinks based on egg. Consequently, current value sales declined by 1% in 2010 over the previous year.

COMPETITIVE LANDSCAPE

  • Sports nutrition is highly fragmented and it is difficult to identify leading players and brands. There is a large number of local importers and distributors, with these supplying Bosnia-Herzegovina mainly with products imported from middle-men in neighbouring countries. Consequently, brands or products that are popular in Sarajevo may not even be available in Banja Luka.

PROSPECTS

  • Sports nutrition is expected to benefit from a growing focus on appearance in Bosnia-Herzegovina during the forecast period. While many women will seek to maintain a slim weight by taking weight management products, a growing number of men will turn to sports nutrition as they seek to bulk up their muscles. Growth is also expected to come from older age groups during the forecast period, as men in their 40s increasingly become interested in building muscle and increasing their health.

CATEGORY DATA

  • Table 75 Sports Nutrition, category rankings 2010
  • Table 76 Sales of Sports Nutrition: Value 2005-2010
  • Table 77 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 78 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 79 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 80 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • The impact of the economic downturn could clearly be seen in vitamins and dietary supplements at the end of the review period. As consumers’ disposable income levels fell in 2010, many sought to reduce expenditure on unnecessary items. Consequently, many consumers cut back on their purchases of vitamins and dietary supplements in order to make ends meet. Vitamins and dietary supplements has an almost luxury image in Bosnia-Herzegovina and few consumers view these products as essential.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • NBTY, Krka and Pharmamed lead sales of vitamins and dietary supplements, with these players accounting for 22%, 13% and 12% value share respectively in 2010. NBTY and Krka were pioneers in vitamins and dietary supplements in Bosnia-Herzegovina, with many consumers remaining loyal to their ranges. Meanwhile domestic manufacturer Pharmamed enjoys strong sales thanks to offering a wide range of popular vitamins and dietary supplements at low prices.

PROSPECTS

  • Vitamins and dietary supplements is expected to return to growth in 2011 with the first signs of recovery in consumers’ disposable income levels. Although they spent less on vitamins and dietary supplements in 2010 then in previous years, consumers continued to take interest in these products. Many are seeking to educate themselves on the subject of vitamins and dietary supplements, with these products benefiting from growing media attention from magazines, TV and websites. Consequently, consumers are expected to have an increasingly sophisticated understanding of vitamins and dietary supplements during the forecast period, which will encourage them to buy a wider range of products.

CATEGORY DATA

  • Table 81 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 82 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 83 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 84 Dietary Supplements by Positioning 2006-2010
  • Table 85 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 86 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 87 Vitamins Brand Shares 2007-2010
  • Table 88 Dietary Supplements Brand Shares 2007-2010
  • Table 89 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 90 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • The range of brands, formats and concepts continued to broaden in weight management towards the end of the review period. Trends tend to come and go quickly in this area, with the emergence of new trends driving sales growth. At the end of the review period, there was particularly strong interest in products based on green coffee, chitosan and apple cider. An increasing number of small regional manufacturers also entered this product area, which offers low entry barriers and the promise of high profits.

COMPETITIVE LANDSCAPE

  • Bozen Cosmetics and GMP Pharmaceuticals lead sales of weight management, accounting for 24% and 21% value share respectively. Bozen’s Turbo Slank brand has been present in the country for over a decade and throughout this time was aggressively advertised. The brand is available in chemists/pharmacies or can be ordered by phone, with the company offering homeshopping. GMP Pharmaceuticals meanwhile offers Herbafast and follows a similar formula to Bozen, using aggressive advertising, sponsoring TV shows and benefiting from celebrity endorsements.

PROSPECTS

  • Consumers are expected to become increasingly focused on their appearance during the forecast period. This will be linked to a growing media focus on appearance but also due to rising obesity rates in the country and rising disposable income levels. Consumers are thus likely to spend an increasingly large portion of their incomes on improving their physical appearance. This trend is expected to benefit sales of weight management during the forecast period.

CATEGORY DATA

  • Table 91 Sales of Weight Management by Category: Value 2005-2010
  • Table 92 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 93 Weight Management Company Shares 2006-2010
  • Table 94 Weight Management Brand Shares 2007-2010
  • Table 95 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 96 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Bosnia-Herzegovina - Category Analysis

HEADLINES

TRENDS

  • Wound care benefited from widening distribution towards the end of the review period. While chemists/pharmacies continued to dominate sales with a value share of 82% in 2010, these products could be found in a widening range of channels in the year. A growing number of supermarkets notably introduced wound care, with this channel thus gaining half a percentage point in value share to account for almost 8% share. Wound care was also introduced into non-store retailing, being offered via vending, homeshopping, internet retailing and direct selling. While sales via these channels remained close to negligible in 2010, this widening availability attracted growing consumer interest.

COMPETITIVE LANDSCAPE

  • Serbian company Galenika led wound care with a value share of 27% for its Flexogal brand in 2010. Galenika benefits from offering the widest distribution for its products, thanks to its strong and long-term relationships with distributors. This player also gained share slightly in 2010 over the previous year, thanks to expanding its presence in supermarkets.

PROSPECTS

  • Growth during the forecast period will mainly be underpinned by widening distribution, with supermarkets in particular likely to offer a widening range of products during the forecast period. This channel could well rise to account for around 25% value share by the end of the forecast period, with consumers attracted by its convenience and by its basic range of affordable products.

CATEGORY DATA

  • Table 97 Sales of Wound Care by Category: Value 2005-2010
  • Table 98 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 99 Wound Care Company Shares 2006-2010
  • Table 100 Wound Care Brand Shares 2007-2010
  • Table 101 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 102 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      RELATED

      Country Report